BiotechTube
Home/Pathalys Pharma/Bastian Dehmel, M.D.
BD

Bastian Dehmel, M.D.

Chief Medical Officer

Pathalys Pharma

Therapeutic Areas

NephrologyChronic Kidney Disease

Pathalys Pharma Pipeline

DrugIndicationPhase
upacicalcetSecondary Hyperparathyroidism (SHPT) in patients receiving hemodialysisPhase 3